Tumors of unknown origin in the bone marrow.

Tumors of unknown origin represent a common presentation of malignancy. However, tumors of unknown origin presenting as bone marrow metastases are infrequently reported. The records of 11,820 bone marrow biopsy procedures over a 15-year period at a university hospital and a veteran's hospital were reviewed, disclosing 25 cases of tumor of unknown primary site. Most of the patients were elderly and presented with bone pain or abdominal pain. Anemia, thrombocytopenia, and a leukoerythroblastic blood picture were common hematologic findings. Examination for detection of the primary site was usually unrewarding. The median survival of patients was very short (18 days) and therapy seldom altered survival.

[1]  H. G. Taylor,et al.  Atypical metastasis from prostate cancer. Clinical utility of the immunoperoxidase technique for prostate-specific antigen. , 1985, JAMA.

[2]  Paul J. Kurtin,et al.  Leukocyte common antigen--a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. , 1985, Human pathology.

[3]  J. Lefante,et al.  A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer , 1983, Breast Cancer Research and Treatment.

[4]  C. Li,et al.  Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin: Immunodiagnosis by prostatic acid phosphatase , 1983, Cancer.

[5]  P. Sheedy,et al.  Computed tomography in search of cancer of unknown origin. , 1982, JAMA.

[6]  Gurmukh Singh,et al.  Bone marrow examination for metastatic tumor. Aspirate and biopsy , 1977, Cancer.

[7]  S Krauss,et al.  A comparison of cyclophosphamide, adriamycin, 5‐fluorouracil (CAF) and cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project , 1977, Cancer.

[8]  W. Broghamer,et al.  The bone marrow biopsy, osteoscan, and peripheral blood in non‐hematopoietic cancer , 1977, Cancer.

[9]  B. Drewinko,et al.  Frequency and significance of bone marrow involvement by metastatic solid tumors , 1977, Cancer.

[10]  G. Bonadonna,et al.  Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.

[11]  W. Swaim,et al.  Bone marrow biopsy with unaltered architecture: a new biopsy device. , 1971, The Journal of laboratory and clinical medicine.

[12]  J. Vaughan,et al.  Leuco‐erythroblastic anæmia , 1936 .

[13]  Q. S. Ringenberg,et al.  Tumors of unknown origin. , 1985, Medical and pediatric oncology.